Unknown PHASE4 INTERVENTIONAL 2-arm NCT03107507

Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG

Efficacy of Levetiracetam in Control of Neonatal Seizures

Sponsor: Cairo University

Interventions Levetiracetam Phenobarbital

Updated 6 times since 2017 Last updated: Apr 5, 2017 Started: Mar 25, 2017 Primary completion: Oct 30, 2017 Completion: Dec 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03107507, this PHASE4 trial focuses on Neonatal Seizures and remains ongoing. Sponsored by Cairo University, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Apr 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Apr 2019 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

May 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cairo University

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo Governorate, Egypt